Electrical cardioversion in patients with left ventricular thrombus: A systematic review of safety and thromboembolic risk
JRSM Cardiovascular Disease · 2026-04 · 15
DOI: 10.1177/20480040261445487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JRSM Cardiovascular Disease, online erschienen am 21.04.2026. Verfasst von Carlson Sama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Heart and Vascular Institute, West Virginia University Hospital, Morgantown, WV, USA. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The thromboembolic risk of electrical cardioversion in patients with left-ventricular (LV) thrombus is poorly defined, producing variable clinical practice. We performed a systematic review to synthesize reported thromboembolic outcomes after cardioversion in patients with imaging-documented LV thrombus.
Methods
We searched PubMed and Scopus through 25 July 2025 for studies reporting outcomes after external direct-current cardioversion or internal/intra-procedural electrical shocks in patients with known LV thrombus. Case reports and pharmacological cardioversion studies were excluded. The primary outcome was clinically apparent thromboembolic complications. Data were extracted and synthesized narratively.
Results
Three retrospective studies met criteria, comprising 68 patients with known, imaging-proven LV thrombus. Thrombus morphology was predominantly laminated/fixed, but about 8% of patients had mobile thrombi in one series. Anticoagulation practices varied; a subset (21%) had no anticoagulation prior to electrical cardioversion. In total, 60 patients underwent direct-current cardioversion while eight patients underwent multiple internal intra-procedural cardioversions in the setting of known LV thrombus. Overall, no thromboembolic events directly attributable to cardioversion were observed over a follow-up period of 3 months to 1 year.
Conclusion
Available evidence, although limited, did not identify clinically overt thromboembolic events after electrical cardioversion in patients with known LV thrombus. Decisions should, however, be individualized, imaging-guided, accompanied by optimized anticoagulation whenever possible and multidisciplinary discussions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Heart and Vascular Institute, West Virginia University Hospital, Morgantown, WV, USA.
- Wheeler Heart and Vascular Center, CoxSouth Medical Centre, Springfield, MO, USA.
- Department of Internal Medicine, University of Iowa, Iowa City, IA, USA.
- Department of Internal Medicine, Icahn School of Medicine at Mount Sinai/Queens, Elmhurst, NY, USA.
- Department of Internal Medicine, West Virginia University Hospital, Morgantown, WV, USA.
ORCID-Profile: Carlson Sama
Zitieren
APA
Sama, C., Chobufo, M. D., Ajibade, A., Mbapah, L. T., Okorigba, E., Rana, S., Al-Saed, M., Muthukumar, L., Havistin, R., & Balla, S. (2026). Electrical cardioversion in patients with left ventricular thrombus: A systematic review of safety and thromboembolic risk. JRSM Cardiovascular Disease, 15. https://doi.org/10.1177/20480040261445487
Vancouver
Sama C, Chobufo MD, Ajibade A, Mbapah LT, Okorigba E, Rana S, et al. Electrical cardioversion in patients with left ventricular thrombus: A systematic review of safety and thromboembolic risk. JRSM Cardiovascular Disease. 2026;15. doi:10.1177/20480040261445487
BibTeX
@article{Sama2026,
author = {Sama, Carlson and Chobufo, Muchi Ditah and Ajibade, Ademola and Mbapah, Leslie Tasha and Okorigba, Efeturi and Rana, Saim and Al-Saed, Mohamad and Muthukumar, Lakshmi and Havistin, Ruby and Balla, Sudarshan},
title = {Electrical cardioversion in patients with left ventricular thrombus: A systematic review of safety and thromboembolic risk},
journal = {JRSM Cardiovascular Disease},
year = {2026},
volume = {15},
doi = {10.1177/20480040261445487}
}
EUVIMED